Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
Year: 2014
Type: review
Abstract: The marine environment harbors a number of macro and micro organisms that have developed unique metabolic abilities to ensure their survival in diverse and hostile habitats, resulting in the biosynthesis of an array of secondary metabolites with specific activities. Several of these metabolites are high-value commercial products for the pharmaceutical and cosmeceutical industries. The aim of this review is to outline the paths of marine natural products discovery and development, with a special focus on the compounds that successfully reached the market and particularly looking at the approaches tackled by the pharmaceutical and cosmetic companies that succeeded in marketing those products. The main challenges faced during marine bioactives discovery and development programs were analyzed and grouped in three categories: biodiversity (accessibility to marine resources and efficient screening), supply and technical (sustainable production of the bioactives and knowledge of the mechanism of action) and market (processes, costs, partnerships and marketing). Tips to surpass these challenges are given in order to improve the market entry success rates of highly promising marine bioactives in the current pipelines, highlighting what can be learned from the successful and unsuccessful stories that can be applied to novel and/or ongoing marine natural products discovery and development programs.
Source: Marine Drugs
DOI: 10.3390/md12021066
Authors: Ana Martins, Helena Vieira, Helena Gaspar, Susana Santos
Institution: University of Lisbon
Language: English
Subfield: Biotechnology
Domain: Life Sciences
SDG: Life below water
Open Access status: gold
Estimated APC paid: $3,499
Awards: G2799240772, Marine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications, BlueGenics – From gene to bioactive product: Exploiting marine genomics for an innovative and sustainable European blue biotechnology industry, G3207356259, G393177772, G5205471977, G5702163051, NIDOS-NOVOS INIBIDORES DE IDO (Indoleamine 2,3-dioxygenase) EXTRAÍDOS DE ESPONJAS MARINHAS DO GÉNERO ERYLUS
OpenAlex ID: W2139857335
